Drugs News and Research

RSS

Regulatory Science Consortium adds 10 new member organizations

Critical Path Institute is proud to announce that the Regulatory Science Consortium, an arm of the Critical Path to TB Drug Regimens, has added 10 new member organizations that include over 100 participants in five workgroups.

30 Apr 2011

Michael Dell shows how information technology can improve efficiency, quality of care today

Michael Dell today shared his insights with healthcare executives on how information technology is being used to improve the efficiency and quality of care today and how IT can support future innovations in prevention, wellness and personalized medicine.

30 Apr 2011

Prescriptions for narcotic-containing drugs often contain too much medication per dose

Parents who give young children prescription painkillers should take extra care to make sure they give just the right amount. What they may be surprised to learn, however, is that the dose given to them by the pharmacy could be too high, according to research to be presented Saturday, April 30, at the Pediatric Academic Societies annual meeting in Denver.

30 Apr 2011

AHF advocates to attend drug giant Abbott Laboratories' Annual General Meeting

A group of advocates from AIDS Healthcare Foundation will attend drug giant Abbott Laboratories' Annual General Meeting Friday April 29 at 9:00am in Abbott Park, Illinois planning to speak at and question Abbott executives regarding Abbott's pricing and policies on its HIV/AIDS medications.

30 Apr 2011

Merck first quarter sales increase 1% to $11.6 billion for 2011

Merck, known as MSD outside the United States and Canada, today announced financial results for the first quarter of 2011.

30 Apr 2011

WHO highlights global threat of NCDs, need for action at Moscow meeting

Non-communicable diseases are a "slow-moving catastrophe" that could overwhelm even the richest countries without action to address their underlying causes, WHO Director-General Margaret Chan said at the First Global Ministerial Conference on Healthy Lifestyles and Non-communicable Disease Control in Moscow on Thursday, the U.N. News Centre reports.

30 Apr 2011

Fetal exposure to crude oil chemical may increase risk of heart disease

While it may be years before the health effects of the 2010 oil spill in the Gulf of Mexico are known, a new study shows that fetal exposure to a chemical found in crude oil is associated with an increased risk of congenital heart disease.

30 Apr 2011

Brain function variations may increase person's risk of drug abuse

One can look at drug addiction as a moral issue, a social ill, or a criminal problem. But Lynn Oswald's experience studying the neuroscience of addiction tells her that it is something else entirely: a disease of the brain.

30 Apr 2011

ETP makes investment to support development of ICVrx's targeted epilepsy drug technology

Epilepsy Therapy Project, a non-profit organization whose mission is to accelerate new therapies for people living with epilepsy and seizures, and ICVrx, LLC, a pharmacy product research and development company focused on novel therapies for central nervous system disorders, announced today that ETP has made an investment in ICVrx to support the development of ICVrx's targeted epilepsy drug technology for patients whose seizures are not controlled by current therapies.

30 Apr 2011

New study identifies less invasive therapy for ACE inhibitor side-effects

A new Henry Ford Hospital study takes a closer look at one of the lesser known, but potential most serious side-effects of ACE inhibitor use - facial, tongue and airway swelling - and identifies a successful and less invasive course of treatment.

29 Apr 2011

Antiviral Drugs Advisory Committee recommends FDA to approve telaprevir for hepatitis C

Vertex Pharmaceuticals Incorporated announced that the Antiviral Drugs Advisory Committee to the U.S. Food and Drug Administration voted unanimously to recommend FDA approval of telaprevir for people with genotype 1 chronic hepatitis C.

29 Apr 2011

Scientists develop novel genetic model of premature aging disorders

Working with a group of national and international researchers, scientists from the Florida campus of The Scripps Research Institute have developed a new genetic model of premature aging disorders that could shed light on these rare conditions in humans and provide a novel platform for large-scale screening of compounds to combat these and other age-related diseases.

29 Apr 2011

Avastin, Lucentis are equally effective for age-related macular degeneration treatment

Age-related macular degeneration, a disease that damages the retina and can destroy central vision, affects approximately 1.6 million Americans. For the past five years, there has been active debate over treatment options for AMD patients because ophthalmologists have not had accurate data regarding the true efficacy of the most commonly used medication.

29 Apr 2011

CTSN focuses on new prairie vole model for autism treatment

Researchers at the Center for Translational Social Neuroscience at Emory University are focusing on prairie voles as a new model to screen the effectiveness of drugs to treat autism.

29 Apr 2011

Researchers discover possible role of SCCA in breast cancer progression

In an analysis of more than 1,300 human breast tissue samples, a team of Stony Brook University School of Medicine researchers discovered a possible role of the squamous cell carcinoma antigen in the progression of breast cancer.

29 Apr 2011

Researchers report Avastin is effective as Lucentis for AMD treatment

Researchers are reporting results from the first year of a two-year clinical trial that Avastin, a drug approved to treat some cancers and that is commonly used off-label to treat age-related macular degeneration, is as effective as the Food and Drug Administration-approved drug Lucentis for the treatment of AMD.

29 Apr 2011

Longer looks: Autism researcher's legacy; methadone for prisoners

Andrew Wakefield has become one of the most reviled doctors of his generation, blamed directly and indirectly, depending on the accuser, for irresponsibly starting a panic with tragic repercussions: vaccination rates so low that childhood diseases once all but eradicated here —whooping cough and measles, among them — have re-emerged, endangering young lives. And yet here he was in Texas, post-career-apocalypse, calmly discussing his work, and a crowd of around 250 people showed up to listen.

29 Apr 2011

Lithium shows hope for Alzheimer’s disease

According to scientists Alzheimer’s disease, a progressively damaging motor neuron condition, could be treated by lithium, a naturally occurring element that is extremely inexpensive and already in use for other psychiatric disorders.

29 Apr 2011

Drug subsidy issues out of PBS’ hands - almost

According to Health Minister Nicola Roxon, expensive drugs have never been automatically listed for subsidy and they can't be now when the government controlling expenses. She added that federal Labor has to balance competing priorities in health and every other department.

29 Apr 2011

Celanese EVA Performance Polymers, PSI partner to develop drug-eluting devices

Particle Sciences Inc., a leading pharmaceutical CRO, and Celanese EVA Performance Polymers, a leading supplier of ethylene vinyl acetate into pharmaceutical applications, are working together to streamline the development of drug-eluting devices.

29 Apr 2011